Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.42−0.07 (-4.70%)
Close on Nov 13, 2026Market cap $1.86MP/E –Yield –
Can-Fite BioPharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -2426.7%, against -1169.1% the year before. The highest annual figure on record is 5004.2% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2426.7% | −1257.5 |
| FY2024 | Dec 31, 2024 | -1169.1% | −141.7 |
| FY2023 | Dec 31, 2023 | -1027.5% | +228.5 |
| FY2022 | Dec 31, 2022 | -1255.9% | +223.0 |
| FY2021 | Dec 31, 2021 | -1478.9% | +414.0 |
| FY2020 | Dec 31, 2020 | -1892.9% | −1271.6 |
| FY2019 | Dec 31, 2019 | -621.3% | −449.3 |
| FY2018 | Dec 31, 2018 | -172.0% | +441.7 |
| FY2017 | Dec 31, 2017 | -613.7% | −5617.9 |
| FY2016 | Dec 31, 2016 | 5004.2% | +1150.5 |
| FY2015 | Dec 31, 2015 | 3853.7% | – |
See a number that looks wrong?